The Globe and Mail reports in its Friday, May 9, edition that Desjardins Securities analyst Frederic Tremblay has reaffirmed his "buy" recommendation for Adentra. The Globe's David Leeder writes in the Eye On Equities column that Mr. Tremblay gave his share target a $5 trim to $41. Analysts on average target the shares at $40.44. Mr. Tremblay says in a note: "Adentra posted solid 1Q25 results as the company continues to efficiently navigate difficult market conditions in 2025. Adentra trades at 5.9 times our 2026 estimate, which is below its historical average of 6.2 times (range of 4.5 8.6 times) and peers at 6.9 times. Our view is that investors can lean on the sector's positive long-term fundamentals and its valuation contraction to find compelling risk/reward propositions. We believe Adentra fits the bill." The Globe reported on Jan. 24 and March 18 that Scotia Capital analyst Jonathan Goldman had reiterated his "sector outperform" ranking for Adentra. The shares could then be had for $36.15 and $27.90. The Globe reported on April 18 that Stifel analyst Ian Gillies continued to rate Adentra "buy." The shares could then be had for $26.93.